Научно-практический журнал
[About us] Journal 'Cytokines & Inflammation'

197376, Санкт-Петербург, ул. Акад. Павлова, д. 12,
Институт экспериментальной медицины РАМН
Тел.: (812) 543 52 14, +7 921 984 11 30, +7 921 909 55 49
Факс: (812) 543 52 14
E-mail:
Web: www.cytokines.ru


  


Year 2018
1-4 issues

About journal

Current year
Archive

Columns
Subscription

Rules for authors

Contact us

Search

Site map

Our partners:
Русский языкEnglish language
Site map Contact us

Contents | Next article | Previous article

Journal 'Cytokines & inflammation', 2012, No. 1

Subscribe for 2019 year

Order this issue

Order PDF of this article

Practitioner Advisor

Number 1'2012

Changes of proinflammatory cytokine serum levels in acute shigellosispatients treated with systemic enzyme therapy

E.G. Rozhkova, A.T. Zhurkin, T.V. Belyaeva, E.A. Kozhukhova,E.A. Alekseieva, G.Yu. Knorring

Clinical and laboratory parameters including changes in levels of serum proinflammatory cytokines (IL-6 and TNFα) were studied in 78 adult patients with acute shigellosis. Some of the patients (n = 35) recieved combination therapy with systemic enzyme Wobenzym. During the clinical manifestation phase of acute shigellosis 31 % of patients showed to have more than 4-fold increase in serum TNFαlevel, and 83 % — over 3.5-fold increase in IL-6 level. The level of IL-6 and the severity of colitis syndrome appeared to be in inverse correlation. An increase in IL-6 concentration by 25 % was detected in patients receiving standard treatment for shigellosis (excluding Wobenzym). Administration of Wobenzym in combination treatment of acute shigellosis helped the levels of IL-6 to remain constant which reduced the duration of colitis clinical manifestations. (Cytokines and Inflammation. 2012. Vol. 11. № 1. P. 114–118.)

Keywords: acute shigellosis, TNFalpha, IL-6, Wobenzym.

Contents | Next article | Previous article


© 2007-2019 Cytokines and inflammation